151 related articles for article (PubMed ID: 31722089)
1. Synergistic induction of drug-metabolizing enzymes in co-cultures of bovine hepatocytic and sinusoidal cell lines.
Yoshioka M; Takenouchi T; Kitani H; Guruge KS; Yamanaka N
In Vitro Cell Dev Biol Anim; 2020 Jan; 56(1):2-9. PubMed ID: 31722089
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the major detoxication functions by phenobarbital and 3-methylcholanthrene in co-cultures of rat hepatocytes and liver epithelial cells.
Lerche C; Fautrel A; Shaw PM; Glaise D; Ballet F; Guillouzo A; Corcos L
Eur J Biochem; 1997 Feb; 244(1):98-106. PubMed ID: 9063451
[TBL] [Abstract][Full Text] [Related]
3. Effect of honokiol on the induction of drug-metabolizing enzymes in human hepatocytes.
Cho YY; Jeong HU; Kim JH; Lee HS
Drug Des Devel Ther; 2014; 8():2137-45. PubMed ID: 25395831
[TBL] [Abstract][Full Text] [Related]
4. Potential impact of steatosis on cytochrome P450 enzymes of human hepatocytes isolated from fatty liver grafts.
Donato MT; Lahoz A; Jiménez N; Pérez G; Serralta A; Mir J; Castell JV; Gómez-Lechón MJ
Drug Metab Dispos; 2006 Sep; 34(9):1556-62. PubMed ID: 16763015
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450-mediated metabolism of triclosan attenuates its cytotoxicity in hepatic cells.
Wu Y; Chitranshi P; Loukotková L; Gamboa da Costa G; Beland FA; Zhang J; Fang JL
Arch Toxicol; 2017 Jun; 91(6):2405-2423. PubMed ID: 27896399
[TBL] [Abstract][Full Text] [Related]
6. Induction of cytochrome P450 (CYP)1A1, CYP1A2, and CYP3A4 but not of CYP2C9, CYP2C19, multidrug resistance (MDR-1) and multidrug resistance associated protein (MRP-1) by prototypical inducers in human hepatocytes.
Runge D; Köhler C; Kostrubsky VE; Jäger D; Lehmann T; Runge DM; May U; Stolz DB; Strom SC; Fleig WE; Michalopoulos GK
Biochem Biophys Res Commun; 2000 Jun; 273(1):333-41. PubMed ID: 10873607
[TBL] [Abstract][Full Text] [Related]
7. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes.
Parkinson A; Mudra DR; Johnson C; Dwyer A; Carroll KM
Toxicol Appl Pharmacol; 2004 Sep; 199(3):193-209. PubMed ID: 15364537
[TBL] [Abstract][Full Text] [Related]
8. Cryopreserved human hepatocytes as alternative in vitro model for cytochrome p450 induction studies.
Garcia M; Rager J; Wang Q; Strab R; Hidalgo IJ; Owen A; Li J
In Vitro Cell Dev Biol Anim; 2003; 39(7):283-7. PubMed ID: 14599235
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of drug-metabolizing enzyme genes in layered co-culture of a human liver cell line and endothelial cells.
Ohno M; Motojima K; Okano T; Taniguchi A
Tissue Eng Part A; 2008 Nov; 14(11):1861-9. PubMed ID: 18847370
[TBL] [Abstract][Full Text] [Related]
10. Efficient assessment of the utility of immortalized Fa2N-4 cells for cytochrome P450 (CYP) induction studies using multiplex quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) and substrate cassette methodologies.
Kenny JR; Chen L; McGinnity DF; Grime K; Shakesheff KM; Thomson B; Riley R
Xenobiotica; 2008 Dec; 38(12):1500-17. PubMed ID: 18989830
[TBL] [Abstract][Full Text] [Related]
11. Constitutive and inducible expression of CYP enzymes in immortal hepatocytes derived from SV40 transgenic mice.
Donato MT; Klocke R; Castell JV; Stenzel K; Paul D; Gómez-Lechón MJ
Xenobiotica; 2003 May; 33(5):459-73. PubMed ID: 12746103
[TBL] [Abstract][Full Text] [Related]
12. Human hepatocyte growth factor down-regulates the expression of cytochrome P450 isozymes in human hepatocytes in primary culture.
Donato MT; Gómez-Lechón MJ; Jover R; Nakamura T; Castell JV
J Pharmacol Exp Ther; 1998 Feb; 284(2):760-7. PubMed ID: 9454825
[TBL] [Abstract][Full Text] [Related]
13. Anti-CD28 monoclonal antibody-stimulated cytokines released from blood suppress CYP1A2, CYP2B6, and CYP3A4 in human hepatocytes in vitro.
Czerwiński M; Kazmi F; Parkinson A; Buckley DB
Drug Metab Dispos; 2015 Jan; 43(1):42-52. PubMed ID: 25326287
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of 23 lots of commercially available cryopreserved hepatocytes for induction assays of human cytochromes P450.
Yajima K; Uno Y; Murayama N; Uehara S; Shimizu M; Nakamura C; Iwasaki K; Utoh M; Yamazaki H
Drug Metab Dispos; 2014 May; 42(5):867-71. PubMed ID: 24553381
[TBL] [Abstract][Full Text] [Related]
15. Induction of drug-metabolizing enzymes by phenobarbital in layered co-culture of a human liver cell line and endothelial cells.
Ohno M; Motojima K; Okano T; Taniguchi A
Biol Pharm Bull; 2009 May; 32(5):813-7. PubMed ID: 19420747
[TBL] [Abstract][Full Text] [Related]
16. Phase I and phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium.
Lakehal F; Wendum D; Barbu V; Becquemont L; Poupon R; Balladur P; Hannoun L; Ballet F; Beaune PH; Housset C
Hepatology; 1999 Dec; 30(6):1498-506. PubMed ID: 10573530
[TBL] [Abstract][Full Text] [Related]
17. Cell lines: a tool for in vitro drug metabolism studies.
Donato MT; Lahoz A; Castell JV; Gómez-Lechón MJ
Curr Drug Metab; 2008 Jan; 9(1):1-11. PubMed ID: 18220566
[TBL] [Abstract][Full Text] [Related]
18. Activity and inducibility of drug-metabolizing enzymes in immortalized hepatocyte-like cells (mhPKT) derived from a L-PK/Tag1 transgenic mouse.
Courjault-Gautier F; Antoine B; Bens M; Vallet V; Cluzeaud F; Pringault E; Kahn A; Toutain H; Vandewalle A
Exp Cell Res; 1997 Aug; 234(2):362-72. PubMed ID: 9260906
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 enzyme activity and protein expression in primary porcine enterocyte and hepatocyte cultures.
Hansen T; Borlak J; Bader A
Xenobiotica; 2000 Jan; 30(1):27-46. PubMed ID: 10659949
[TBL] [Abstract][Full Text] [Related]
20. In vitro assessment of P450 induction potential of novel chemopreventive agents SR13668, 9-cis-UAB30, and pentamethychromanol in primary cultures of human hepatocytes.
Jackson JP; Kabirov KK; Kapetanovic IM; Lyubimov A
Chem Biol Interact; 2009 May; 179(2-3):263-72. PubMed ID: 19135037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
